Related Experiment Video

Updated: Aug 24, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex

Andrew Wilkins1, Qinggong Ping, Christopher L Carpenter

  • 1Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

Genes & Development
|April 27, 2004
PubMed

Insights

RhoBTB2, a candidate tumor suppressor, interacts with Cul3 ubiquitin ligase. Its regulation by the ubiquitin-proteasome system is crucial for preventing increased protein levels in cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Rhobtb2 is a candidate tumor suppressor gene located on chromosome 8p21, a region frequently deleted in various cancers.
  • Gene expression of Rhobtb2 is significantly reduced or absent in a substantial proportion of breast and lung cancer cell lines.
  • RhoBTB2 is an atypical Rho GTPase with unknown function, characterized by Rho GTPase and two BTB domains.

Purpose of the Study:

  • To elucidate the function of RhoBTB2 in cancer, specifically its interaction with ubiquitin ligase complexes.
  • To investigate the mechanism by which RhoBTB2 is regulated and its role in tumor suppression.
  • To analyze the impact of mutations on RhoBTB2's interaction with Cul3 and its protein stability.

Main Methods:

  • Investigated the binding of RhoBTB2 to the Cul3 ubiquitin ligase scaffold using its BTB domain.
  • Utilized in vitro and in vivo assays to determine if RhoBTB2 is a substrate for Cul3-based ubiquitin ligase complexes.
  • Analyzed a RhoBTB2 missense mutant from a lung cancer cell line for its ability to bind Cul3 and its regulation by the ubiquitin/proteasome system.

Main Results:

  • Demonstrated that RhoBTB2 binds to Cul3 via its first BTB domain.
  • Confirmed that RhoBTB2 is a substrate for a Cul3-based ubiquitin ligase complex, indicating its degradation pathway.
  • Showed that a specific RhoBTB2 mutant fails to bind Cul3 and is not degraded by the ubiquitin/proteasome system, leading to elevated protein levels.

Conclusions:

  • Proposed a model where RhoBTB2 acts as a tumor suppressor by facilitating the degradation of target proteins via a Cul3 ubiquitin ligase complex.
  • Highlighted the importance of RhoBTB2-Cul3 interaction and ubiquitin-proteasome system regulation in preventing uncontrolled RhoBTB2 protein accumulation.
  • Identified a potential mechanism of oncogenesis involving dysfunctional RhoBTB2 in cancer cells.

More Related Videos

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta10:27

Functional Characterization of RING-Type E3 Ubiquitin Ligases In Vitro and In Planta

Published on: December 5, 2019

Related Concept Videos

Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Cotranslational Protein Translocation01:20

Cotranslational Protein Translocation

Translocation of proteins across membranes is an ancient process that occurs even in bacteria and archaebacteria. In fact, the components of the translocation machinery are still conserved between prokaryotes and eukaryotes.
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
Protein Translocation Machinery on the ER Membrane01:28

Protein Translocation Machinery on the ER Membrane

The translocon complex situated on the ER membrane is the main gateway for the protein secretory pathway. It facilitates the transport of nascent peptides into the ER lumen and their insertion into the ER membrane.
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the translocon complex.
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Post-translational Translocation of Proteins to the RER01:27

Post-translational Translocation of Proteins to the RER

A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Rab Cascades01:25

Rab Cascades

Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.